Titan Pharmaceuticals (NASDAQ:TTNP) Stock Price Passes Below 200 Day Moving Average of $7.17

Titan Pharmaceuticals, Inc. (NASDAQ:TTNP)’s stock price passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $7.17 and traded as low as $7.01. Titan Pharmaceuticals shares last traded at $7.01, with a volume of 602 shares.

Analysts Set New Price Targets

Separately, StockNews.com began coverage on shares of Titan Pharmaceuticals in a report on Tuesday. They set a “sell” rating on the stock.

Titan Pharmaceuticals Price Performance

The company has a market cap of $6.34 million, a price-to-earnings ratio of -0.85 and a beta of 1.33. The business’s fifty day moving average price is $7.36 and its 200 day moving average price is $7.16.

Titan Pharmaceuticals Company Profile

Titan Pharmaceuticals, Inc, a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform. The company offers Probuphine implant for the maintenance treatment of opioid use disorder in clinically stable patients in the United States, Canada, and the European Union.